Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 106

Sort by

Sort Order Select

Journal Articles

Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520

Matteo Marchesini, PhD, Andrea Gherli, Anna Montanaro, Samuel Kitara, Claudia Sorrentino, Luca Pagliaro, Anne-Marie Lund Winter, Chiara Rompietti, Donatella Stilli, Federica Rizzi, Kimberly Stegmaier, MD, Paolo Sportoletti, William Dalby-Brown, Giovanni Roti

Blood (2019) 134 (Supplement_1): 407.

https://doi.org/10.1182/blood-2019-125616

Published: 2019

Journal Articles

Urban-Rural Variation in Use of Thrombolytic Therapy for Pulmonary Embolism

Jeremy Y Feng, MD, Charles B Ross, MD FACS, FSVS, Rachel P Rosovsky, MDMPH

Blood (2019) 134 (Supplement_1): 3409.

https://doi.org/10.1182/blood-2019-125493

Published: 2019

Journal Articles

Association of Endothelial Biomarkers with Cerebral MRI Perfusion Analysis in Patients with Sickle Cell Disease

Liza Afzali-Hashemi, Lena Vaclavu, PhD, Erfan Nur, MD PhD, Aart J Nederveen, PhD, Bart J. Biemond, MD PhD

Blood (2019) 134 (Supplement_1): 1000.

https://doi.org/10.1182/blood-2019-124688

Published: 2019

Journal Articles

Saskatoon Urban Hospital Frozen Plasma Utilization and Appropriateness Audit

Jennifer E Leung, MD, Heather Panchuk, Oksana C. Prokopchuk-Gauk, MDBSc

Blood (2018) 132 (Supplement 1): 5074.

https://doi.org/10.1182/blood-2018-99-114176

Published: 2018

Journal Articles

Reduced Cerebral Metabolic Rate of Oxygen in Adults with Sickle Cell Disease

Lena Vaclavu, Esben Thade Petersen, PhD, Ed T VanBavel, PhD, Charles BL Majoie, MD PhD, Aart J Nederveen, PhD, Bart J. Biemond, MD PhD

Blood (2018) 132 (Supplement 1): 11.

https://doi.org/10.1182/blood-2018-99-116194

Published: 2018

Journal Articles

Overcoming a Critical Obstacle Towards Effective and Safe CAR T-Cell Therapeutics

Nandini Mondal, PhD, Mariana Silva, PhD, Ana Castano, MD, Marcela V. Maus, MD PhD, Robert Sackstein, MD PhD

Blood (2018) 132 (Supplement 1): 2056.

https://doi.org/10.1182/blood-2018-99-118675

Published: 2018

Journal Articles

A Pooled Analysis of Survival By Defibrotide Timing of Initiation in Adults with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Following Hematopoietic Stem Cell Transplant (HSCT)

Paul Richardson, Enric Carreras, Antonio Pagliuca, Robert Ryan, William Tappe, Mohamad Mohty, MD PhD

Blood (2018) 132 (Supplement 1): 815.

https://doi.org/10.1182/blood-2018-99-113099

Published: 2018

Journal Articles

Reduced Cerebrovascular Reserve Capacity in Adults with Sickle Cell Disease

Lena Vaclavu, MSc, Lena Vaclavu, Henri JMM Mutsaerts, PhD, Esben Thade Petersen, PhD, Ed T VanBavel, PhD, John C Wood, MD PhD, Charles BL Majoie, MD PhD, Aart J Nederveen, PhD, Bart J. Biemond, MD PhD

Blood (2017) 130 (Supplement 1): 972.

https://doi.org/10.1182/blood.V130.Suppl_1.972.972

Published: 2017

Journal Articles

Romiplostim (Nplate®) and Oprelvekin (Neumega®) Correct Thrombocytopenia in TAR Syndrome (Thrombocytopenia with Absent Radii)

Nicolas Gallastegui, MD, Pamela B. Dudkiewicz, DNP, ARNP, Wenche Jy, PhD, Lawrence L. Horstman, BS, Yeon S. Ahn, MD

Blood (2017) 130 (Supplement 1): 4953.

https://doi.org/10.1182/blood.V130.Suppl_1.4953.4953

Published: 2017

Journal Articles

Blood Loss in Rivaroxaban Anticoagulated Pigs with Severe Polytrauma Is Significantly Reduced By Early Therapy with Prothrombin Complex Concentrate

Oliver Grottke, MD PhD MPH, Necib Akman, MD, Till Braunschweig, MD, Markus Honickel, MD, Hugo ten Cate, MD PhD

Blood (2017) 130 (Supplement 1): 2392.

https://doi.org/10.1182/blood.V130.Suppl_1.2392.2392

Published: 2017

Journal Articles

Factors Associated with Pulmonary Hypertension and Overall Survival in Adult Patients with Sickle Cell Disease: A Single Centre Retrospective Study

Anu Paul, MD, Shashank Cingam, MD, Runhua Shi, Samip R Master, MD, Richard Preston Mansour, MD

Blood (2017) 130 (Supplement 1): 4788.

https://doi.org/10.1182/blood.V130.Suppl_1.4788.4788

Published: 2017

Journal Articles

Temporary and Permanent Inferior Vena Cava Filters in the Oncology Population

Suneel Deepak Kamath, MD, Elizabeth H. Cull, MD, Brady L. Stein, MD, Robert Lewandowski, MD, Brandon McMahon, MD

Blood (2016) 128 (22): 1423.

https://doi.org/10.1182/blood.V128.22.1423.1423

Published: 2016

Journal Articles

Platelets from Fresh and Cold-Stored Whole Blood Contribute to Clot Formation after Transfusion in Rats with Acute Traumatic Coagulopathy

Xiaowu Wu, MD MMSc, Robbie Montgomery, MS, Bin Liu, BS, Jeffrey D Keesee, BS, Avi Benov, MD, Daniel N Darlington, PhD, Andrew P Cap, MD PhD

Blood (2016) 128 (22): 1457.

https://doi.org/10.1182/blood.V128.22.1457.1457

Published: 2016

Journal Articles

Suppression of the Hemodynamic Response Function Demonstrates Altered Cerebral Vasoreactivity in Sickle Cell Disease

Melanie E. Fields, MD MSCI, Rebecca Coalson, Liam Comiskey, Mario Ortega, PhD, Dustin K. Ragan, PhD, Allison King, MD MPH, PhD, Joshua Shimony, MD PhD, Andria L. Ford, MD MSCI, Jin-Moo Lee, MD PhD, Nico Dosenbach, MD PhD

Blood (2016) 128 (22): 12.

https://doi.org/10.1182/blood.V128.22.12.12

Published: 2016

Journal Articles

Arterio-Venous Fistula Is an Applicable Vascular Access for Erythracytapheresis in Patients with Sickle Cell Disease

Blood (2016) 128 (22): 4856.

https://doi.org/10.1182/blood.V128.22.4856.4856

Published: 2016

Journal Articles

The Intensive Care Trial for Critically Ill Onco-Haematologic Patients: The Need for Response Criteria at 5 Days of Full Treatment to Separate Good Risk Patients and Avoid Futile Intensive Care Interventions

Blood (2016) 128 (22): 5987.

https://doi.org/10.1182/blood.V128.22.5987.5987

Published: 2016

Journal Articles

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Treatment of Cancer-Associated Thrombosis

Aaron P Soff, Judy Dong, MD, Simon Mantha, MD MPH, Gerald A. Soff, MD

Blood (2016) 128 (22): 2619.

https://doi.org/10.1182/blood.V128.22.2619.2619

Published: 2016

Journal Articles

Durable Remissions in Children with Relapsed/Refractory ALL Treated with T Cells Engineered with a CD19-Targeted Chimeric Antigen Receptor (CTL019)

Stephan A. Grupp, MD PhD, Shannon L Maude, MD PhD, Pamela A Shaw, PhD, Richard Aplenc, MD PhD, David M. Barrett, MD PhD, Colleen Callahan, MSN, Simon F. Lacey, PhD BS, Bruce L. Levine, PhD, J Joseph Melenhorst, PhD, Laura Motley, RN, Susan R. Rheingold, MD, David T Teachey, MD, Patricia A. Wood, MD PhD, David Porter, MD, Carl H. June, MD

Blood (2015) 126 (23): 681.

https://doi.org/10.1182/blood.V126.23.681.681

Published: 2015

Journal Articles

Autologous Hematopoietic Progenitor Cell Infusion Adverse Event Associated with Apheresis Product Granulocyte Content

Araci M. Sakashita, MD, Andrea Tiemi Kondo, MD, Ana Paula Hitomi Yokoyama, MD, Carolina Bonet Bub, MD, Sanny Marcele da Costa Lira, MD, Cristiane Yoshie Nakazawa, MD, Andrea Neri Folchini Cipolletta, RN, Nelson Hamerschlak, PhD, Jose M Kutner, MD PhD

Blood (2015) 126 (23): 4308.

https://doi.org/10.1182/blood.V126.23.4308.4308

Published: 2015

Journal Articles

A Novel Targeted Approach to the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) with an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody (mAb), NI-0501: First Results from a Pilot Phase 2 Study in Children with Primary HLH

Michael Jordan, MD, Franco Locatelli Prof, MD, PhD, Carl Allen, MD, PhD, Fabrizio De Benedetti, MD, PhD, Alexei A. Grom, Maria Ballabio, MD, Walter Giovanni Ferlin, PhD, NI-0501-04 Study Group, Cristina De Min, MD

Blood (2015) 126 (23): LBA-3.

https://doi.org/10.1182/blood.V126.23.LBA-3.LBA-3

Published: 2015

NARROW

Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520

Urban-Rural Variation in Use of Thrombolytic Therapy for Pulmonary Embolism

Association of Endothelial Biomarkers with Cerebral MRI Perfusion Analysis in Patients with Sickle Cell Disease

Saskatoon Urban Hospital Frozen Plasma Utilization and Appropriateness Audit

Reduced Cerebral Metabolic Rate of Oxygen in Adults with Sickle Cell Disease

Overcoming a Critical Obstacle Towards Effective and Safe CAR T-Cell Therapeutics

A Pooled Analysis of Survival By Defibrotide Timing of Initiation in Adults with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Following Hematopoietic Stem Cell Transplant (HSCT)

Reduced Cerebrovascular Reserve Capacity in Adults with Sickle Cell Disease

Romiplostim (Nplate®) and Oprelvekin (Neumega®) Correct Thrombocytopenia in TAR Syndrome (Thrombocytopenia with Absent Radii)

Blood Loss in Rivaroxaban Anticoagulated Pigs with Severe Polytrauma Is Significantly Reduced By Early Therapy with Prothrombin Complex Concentrate

Factors Associated with Pulmonary Hypertension and Overall Survival in Adult Patients with Sickle Cell Disease: A Single Centre Retrospective Study

Temporary and Permanent Inferior Vena Cava Filters in the Oncology Population

Platelets from Fresh and Cold-Stored Whole Blood Contribute to Clot Formation after Transfusion in Rats with Acute Traumatic Coagulopathy

Suppression of the Hemodynamic Response Function Demonstrates Altered Cerebral Vasoreactivity in Sickle Cell Disease

Arterio-Venous Fistula Is an Applicable Vascular Access for Erythracytapheresis in Patients with Sickle Cell Disease

The Intensive Care Trial for Critically Ill Onco-Haematologic Patients: The Need for Response Criteria at 5 Days of Full Treatment to Separate Good Risk Patients and Avoid Futile Intensive Care Interventions

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Treatment of Cancer-Associated Thrombosis

Durable Remissions in Children with Relapsed/Refractory ALL Treated with T Cells Engineered with a CD19-Targeted Chimeric Antigen Receptor (CTL019)

Autologous Hematopoietic Progenitor Cell Infusion Adverse Event Associated with Apheresis Product Granulocyte Content

A Novel Targeted Approach to the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) with an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody (mAb), NI-0501: First Results from a Pilot Phase 2 Study in Children with Primary HLH

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only